Thienothiazines

(S)-6-Chloro-4-hydroxy-3,4-dihydro-2H-thieno[3,2-e][1,2]thiazine 1,1-Dioxide 98.0+%, TCI America™

CAS: 160982-16-1 Molecular Formula: C6H6ClNO3S2 Molecular Weight (g/mol): 239.688 MDL Number: MFCD09033311 InChI Key: OFJGKGNJDCLNPM-SCSAIBSYSA-N PubChem CID: 11746721 IUPAC Name: (4S)-6-chloro-1,1-dioxo-3,4-dihydro-2H-thieno[3,2-e]thiazin-4-ol SMILES: C1C(C2=C(SC(=C2)Cl)S(=O)(=O)N1)O

Brinzolamide 98.0+%, TCI America™

CAS: 138890-62-7 Molecular Formula: C12H21N3O5S3 Molecular Weight (g/mol): 383.496 MDL Number: MFCD08067749 InChI Key: HCRKCZRJWPKOAR-JTQLQIEISA-N Synonym: (R)-4-(Ethylamino)-2-(3-methoxypropyl)-3,4-dihydro-2H-thieno[3,2-e][1,2]thiazine-6-sulfonamide 1,1-Dioxide PubChem CID: 68844 ChEBI: CHEBI:41212 IUPAC Name: (4R)-4-(ethylamino)-2-(3-methoxypropyl)-1,1-dioxo-3,4-dihydrothieno[3,2-e]thiazine-6-sulfonamide SMILES: CCNC1CN(S(=O)(=O)C2=C1C=C(S2)S(=O)(=O)N)CCCOC

Lornoxicam 98.0+%, TCI America™

CAS: 70374-39-9 Molecular Formula: C13H10ClN3O4S2 Molecular Weight (g/mol): 371.81 MDL Number: MFCD00866163 InChI Key: WLHQHAUOOXYABV-UHFFFAOYSA-N Synonym: 6-Chloro-4-hydroxy-2-methyl-N-(2-pyridyl)-2H-thieno[2,3-e][1,2]thiazine-3-carboxamide 1,1-Dioxide PubChem CID: 54690031 ChEBI: CHEBI:31783 IUPAC Name: 6-chloro-4-hydroxy-2-methyl-1,1-dioxo-N-pyridin-2-ylthieno[2,3-e]thiazine-3-carboxamide SMILES: CN1C(=C(C2=C(S1(=O)=O)C=C(S2)Cl)O)C(=O)NC3=CC=CC=N3

Medchemexpress LLC 2H-Thieno[2,3-e]-1,2-thiazine-3-carboxamide, 6-chloro-4-hydroxy-2-methyl-N-2-pyridinyl- | 70374-39-9 | >99.3% | 500 MG

Small and Specialty Supplier Partner
Small and/or specialty supplier based on Federal laws and SBA requirements.
Learn More

2H-Thieno[2,3-e]-1,2-thiazine-3-carboxamide, 6-chloro-4-hydroxy-2-methyl-N-2-pyridinyl- | 70374-39-9 | >99.3% | 500 MG

Medchemexpress LLC Lornoxicam | 70374-39-9 | 98.7% | 1 ML

Small and Specialty Supplier Partner
Small and/or specialty supplier based on Federal laws and SBA requirements.
Learn More

Lornoxicam is an orally active nonsteroidal anti-inflammatory drug (NSAID) that demonstrates analgesic, anti-inflammatory, antipyretic, and anticancer properties. It effectively inhibits both COX-1 and COX-2, as well as the production of NO by iNOS and the proinflammatory cytokine IL-6. This compound also inhibits tumor cell proliferation and migration and induces tumor cell apoptosis, making it suitable for research into inflammatory pain, colorectal cancer, and breast cancer.

• Orally active nonsteroidal anti-inflammatory drug (NSAID)
• Exhibits analgesic, anti-inflammatory, antipyretic, and anticancer activities
• Effectively inhibits COX-1 and COX-2
• Inhibits NO production by iNOS
• Inhibits proinflammatory cytokine IL-6
• Inhibits tumor cell proliferation and migration
• Induces tumor cell apoptosis
• Useful in inflammatory pain, colorectal cancer, and breast cancer studies

Apexbio Technology LLC Lornoxicam 70374-39-9 200mg

Small and Specialty Supplier Partner
Small and/or specialty supplier based on Federal laws and SBA requirements.
Learn More

Lornoxicam (CAS 70374-39-9) is an oxicam-class nonsteroidal anti-inflammatory drug (NSAID) that exerts its pharmacological effects primarily by potent inhibition of cyclooxygenase isoforms COX-1 and COX-2 with in vitro IC50 values of 5 nM and 8 nM respectively Studies in intact human cells and whole blood confirm its strong suppressive activity against both COX isoenzymes Additionally lornoxicam displays dose-dependent inhibition of nitric oxide formation (IC50 65 M) and reduction of IL-6 production in vitro Due to its robust COX inhibition and favorable pharmacokinetic profile lornoxicam is widely utilized as a research tool in studies investigating inflammation pain pathways and COX-mediated prostaglandin synthesis

Apexbio Technology LLC Lornoxicam 70374-39-9 10mM (in 1mL DMSO)

Small and Specialty Supplier Partner
Small and/or specialty supplier based on Federal laws and SBA requirements.
Learn More

Lornoxicam (CAS 70374-39-9) is an oxicam-class nonsteroidal anti-inflammatory drug (NSAID) that exerts its pharmacological effects primarily by potent inhibition of cyclooxygenase isoforms COX-1 and COX-2 with in vitro IC50 values of 5 nM and 8 nM respectively Studies in intact human cells and whole blood confirm its strong suppressive activity against both COX isoenzymes Additionally lornoxicam displays dose-dependent inhibition of nitric oxide formation (IC50 65 M) and reduction of IL-6 production in vitro Due to its robust COX inhibition and favorable pharmacokinetic profile lornoxicam is widely utilized as a research tool in studies investigating inflammation pain pathways and COX-mediated prostaglandin synthesis